
Roxinta 50mg Tablet DT
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Roxithromycin (50mg)
Overview Roxinta 50mg Tablet DT
Pediatric antibiotic Roxinta 50mg Tablet DT effectively combats various bacterial infections affecting the ears, nose, lungs, teeth, skin, and urinary tract. Administer this medication orally to your child, ideally 15 minutes before or 3 hours after meals to optimize absorption; however, a small amount of food may be given with the tablet if stomach upset occurs. The typical dosage is twice daily, morning and evening, as directed by your physician. The prescribed dosage, timing, and method are crucial and depend on the infection's type, severity, and your child's age and weight. Treatment usually lasts 5-10 days, guided by the infection's response and severity. Complete the entire course; premature cessation can worsen the condition or lead to recurrence. If your child vomits within 30 minutes, reassure them and repeat the dose. Mild, transient side effects, such as nausea, vomiting, diarrhea, or stomach ache, may occur but typically resolve. Persistent or troubling side effects warrant immediate consultation with your child's doctor. Always inform the physician of any pre-existing allergies, heart conditions, liver issues, or kidney problems to ensure appropriate dosage and treatment planning.
Primary Ingredients of Roxinta 50mg Tablet DT
No information provided. Therefore, no text can be rewritten.
Uses of Roxinta 50mg Tablet DT
Managing bacterial illnesses
Major Benefits of Roxinta 50mg Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always dissolve one tablet in water before consumption. Roxinta 50mg DT tablets should be ingested on an empty stomach.
How to use Roxinta 50mg Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Dissolve the Roxinta 50mg Tablet DT in water before consumption. Administer on an empty stomach.
How Roxinta 50mg Tablet DT works:
Roxinta 50mg Delayed-Release Tablets are a bacterial infection medication. Their mechanism of action involves disrupting the production of vital bacterial proteins, thus hindering bacterial growth and propagation, thereby controlling the infection.
SAFETY ADVICE
AlcoholSAFE
Roxinta 50mg Tablet DT may be taken with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The use of Roxinta 50mg Tablet DT during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nonetheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation and Roxinta 50mg DT tablets are compatible. Research in humans indicates negligible transfer of the medication into breast milk, posing no discernible risk to the infant.
DrivingUNSAFE
Driving should be avoided if taking Roxinta 50mg Tablet DT, as this medication may cause drowsiness, blurred vision, and dizziness, reducing alertness.
KidneySAFE IF PRESCRIBED
The use of Roxinta 50mg Tablet DT in individuals with kidney disease appears to pose minimal risk. Current evidence indicates dose alteration may be unnecessary for these patients, although a physician's consultation is recommended. Similarly, roxithromycin is typically well-tolerated by children exhibiting mild to moderate kidney dysfunction, and dosage adjustments are usually not necessary.
LiverCAUTION
Caution is advised when administering Roxinta 50mg Tablet DT to individuals with hepatic impairment; dosage modification may be necessary. Seek medical advice. If symptoms suggestive of hepatitis, such as emesis, pallor, and asthenia, appear, cease Roxinta 50mg Tablet DT use immediately.
What if you forget to take Roxinta 50mg Tablet DT :
Remain calm. Unless otherwise directed by your child's physician, administer the missed dose immediately upon recollection. However, if the next dose is imminent, simply give that dose at the scheduled time. Avoid doubling the prescribed dosage.
Facts to Know About Roxinta 50mg Tablet DT
| Label | Value |
|---|---|
| Chemical Type | Modified macrolide antibiotic |
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
| Action Class | Macrolide antibiotics |
